Automated Liquid Handling Platforms Boost Productivity of Synthetic Biology Researchers
|
By LabMedica International staff writers Posted on 21 Feb 2013 |

Image: The Freedom EVO workstation (Photo courtesy of Tecan).
Use of automated robotic liquid handling workstations is giving a dramatic push to development efforts in the exciting new field of synthetic biology.
Synthetic biology is the design and construction of new biological entities such as enzymes, genetic circuits, and cells, or the redesign of existing biological systems. Synthetic biology builds on the advances in molecular, cell, and systems biology and seeks to transform biology in the same way that synthesis transformed chemistry and integrated circuit design transformed computing.
The element that distinguishes synthetic biology from traditional molecular and cellular biology is the focus on the design and construction of core components (parts of enzymes, genetic circuits, metabolic pathways, etc.) that can be modeled, understood, and tuned to meet specific performance criteria, and the assembly of these smaller parts and devices into larger integrated systems that solve specific problems. Just as engineers now design integrated circuits based on the known physical properties of materials and then fabricate functioning circuits and entire processors (with relatively high reliability), synthetic biologists will soon design and build engineered biological systems. Unlike many other areas of engineering, biology is nonlinear and less predictable, and there is less knowledge of the parts and how they interact. Hence, the overwhelming physical details of natural biology (gene sequences, protein properties, biological systems) must be organized and recast via a set of design rules that hide information and manage complexity, thereby enabling the engineering of many-component integrated biological systems. It is only when this is accomplished that designs of significant scale will be possible.
Synthetic biologists at the Massachusetts Institute of Technology (Cambridge) have adapted a Tecan (Männedorf, Switzerland) Freedom EVO workstation to help them in the development of genetic circuits. By automating laborious liquid handling protocols, the platform has increased throughput from just a few samples to hundreds of experiments a day.
The Tecan Freedom EVO series offers worktables with building-block modularity that ensures precision, reliable liquid handling, and easy-to-use robotics. Each platform can be combined with a wide choice of robotic arms, liquid handling tools, and application options powered by straightforward software that can be programmed to meet the needs of each individual laboratory. The EVO platform allows a choice of pipetting technologies on the same platform, including the possibility of combining both air and liquid displacement on a single workstation.
"We specifically chose a Tecan system for this application because the software and hardware are easy to extend, and we wanted the flexibility to experiment with different combinations of modules," said Dr. Jonathan Babb, a post-doctoral researcher at the Massachusetts Institute of Technology. "The Freedom EVOware software has an open architecture, making it easy to write and develop scripts and connect the instrument to our own systems and software, and the design of the hardware undoubtedly helps with the integration of our own modules and apparatus onto the worktable. For example, we wanted to be able to store enzymes at -20 degrees Celsius on the deck, and were able to get an automation-friendly chiller that could do this at fairly low cost, without having to make any major modifications to the platform. We have also been able to devise our own colony picking procedures for cell-based screening, and to set up and run an ordinary, low-cost gel station on the platform. The Freedom EVO is able to automatically load and run gels on the gel station, despite the lack of a communication port on this device, eliminating the need for a lot of expensive additional hardware. The flexibility and programmability of the Freedom EVO are invaluable for this, allowing us to rapidly develop in-house solutions and create the elaborate algorithms that are required to perform the many different steps that are necessary for the assembly of genetic circuits. We have successfully demonstrated that every step in the process can be automated and run completely unattended, and are now scaling up to high throughput mode, which will see multiple 96-well plates processed per day."
Related Links:
Massachusetts Institute of Technology
Tecan
Synthetic biology is the design and construction of new biological entities such as enzymes, genetic circuits, and cells, or the redesign of existing biological systems. Synthetic biology builds on the advances in molecular, cell, and systems biology and seeks to transform biology in the same way that synthesis transformed chemistry and integrated circuit design transformed computing.
The element that distinguishes synthetic biology from traditional molecular and cellular biology is the focus on the design and construction of core components (parts of enzymes, genetic circuits, metabolic pathways, etc.) that can be modeled, understood, and tuned to meet specific performance criteria, and the assembly of these smaller parts and devices into larger integrated systems that solve specific problems. Just as engineers now design integrated circuits based on the known physical properties of materials and then fabricate functioning circuits and entire processors (with relatively high reliability), synthetic biologists will soon design and build engineered biological systems. Unlike many other areas of engineering, biology is nonlinear and less predictable, and there is less knowledge of the parts and how they interact. Hence, the overwhelming physical details of natural biology (gene sequences, protein properties, biological systems) must be organized and recast via a set of design rules that hide information and manage complexity, thereby enabling the engineering of many-component integrated biological systems. It is only when this is accomplished that designs of significant scale will be possible.
Synthetic biologists at the Massachusetts Institute of Technology (Cambridge) have adapted a Tecan (Männedorf, Switzerland) Freedom EVO workstation to help them in the development of genetic circuits. By automating laborious liquid handling protocols, the platform has increased throughput from just a few samples to hundreds of experiments a day.
The Tecan Freedom EVO series offers worktables with building-block modularity that ensures precision, reliable liquid handling, and easy-to-use robotics. Each platform can be combined with a wide choice of robotic arms, liquid handling tools, and application options powered by straightforward software that can be programmed to meet the needs of each individual laboratory. The EVO platform allows a choice of pipetting technologies on the same platform, including the possibility of combining both air and liquid displacement on a single workstation.
"We specifically chose a Tecan system for this application because the software and hardware are easy to extend, and we wanted the flexibility to experiment with different combinations of modules," said Dr. Jonathan Babb, a post-doctoral researcher at the Massachusetts Institute of Technology. "The Freedom EVOware software has an open architecture, making it easy to write and develop scripts and connect the instrument to our own systems and software, and the design of the hardware undoubtedly helps with the integration of our own modules and apparatus onto the worktable. For example, we wanted to be able to store enzymes at -20 degrees Celsius on the deck, and were able to get an automation-friendly chiller that could do this at fairly low cost, without having to make any major modifications to the platform. We have also been able to devise our own colony picking procedures for cell-based screening, and to set up and run an ordinary, low-cost gel station on the platform. The Freedom EVO is able to automatically load and run gels on the gel station, despite the lack of a communication port on this device, eliminating the need for a lot of expensive additional hardware. The flexibility and programmability of the Freedom EVO are invaluable for this, allowing us to rapidly develop in-house solutions and create the elaborate algorithms that are required to perform the many different steps that are necessary for the assembly of genetic circuits. We have successfully demonstrated that every step in the process can be automated and run completely unattended, and are now scaling up to high throughput mode, which will see multiple 96-well plates processed per day."
Related Links:
Massachusetts Institute of Technology
Tecan
Latest BioResearch News
- Inherited Genetic Differences Help Explain Variable CAR T-Cell Therapy Outcomes
- AI-Powered Genome Mapping Reveals New Layer of Alzheimer’s Disease Biology
- Genetic Variations Reveal Mechanisms Behind Sudden Cardiac Death Risk
- Immune Biomarkers Support Early Risk Stratification in Oral Precancer
- Global Genetic Map Identifies Regional Parkinson’s Variants to Support Diagnostics
- Breakthrough Genetic Map Advances Understanding of Bone Disorders
- Study Identifies Hereditary Subtype of Aggressive Prostate Cancer
- Gene Variants Linked to Pollution-Exacerbated Asthma
- Single-Cell Analysis Mapping Links Inflammation Response to Acute Myeloid Leukemia
- Study Reveals New Insights into Rare Blood Cancer Development
- New Findings Clarify Molecular Drivers of Rare Small Intestinal Cancer
- Lung Cancer Study Reveals Cellular Program Behind Therapy Resistance
- Tumor Genome Marker May Predict Treatment Benefit in Pediatric Cancers
- Lysosomal Gene Defect Linked to Severe Childhood Brain Disorders
- Genetic Testing Identifies Greater Inherited Sudden Cardiac Arrest Risk in Younger Individuals
- Hidden 'Jumping Gene' Variant Linked to Higher Pancreatic Cancer Risk
Channels
Clinical Chemistry
view channel
Machine Learning Model Shows Promise for Improving Metanephrine Testing Accuracy
Pheochromocytomas and paragangliomas are rare tumors that form in or near the adrenal glands and cause overproduction of stress hormones. Plasma-free metanephrines are the recommended first-line test,... Read more
Common HbA1c Assay May Miss Diabetes in People with Sickle Cell Trait
Accurate diabetes detection is essential because early identification guides timely management, yet test performance can vary in people with hemoglobin variants such as sickle cell trait.... Read moreMolecular Diagnostics
view channel
AI Tool Improves Long-Read Detection of Cancer Mutations
Accurate identification of somatic mutations remains difficult, particularly in structurally complex genomic regions. Short-read sequencing pipelines can miss clinically relevant variants, limiting research... Read more
FDA Clears Molecular Test for Bacterial Vaginosis and Candida Vaginitis
Vaginitis is a common reason for clinical visits, with bacterial vaginosis and Candida vaginitis among the leading causes. Overlapping symptoms and reliance on microscopy, pH testing, and clinical observation... Read moreHematology
view channel
Age-Specific CBC Reference Intervals Support Pediatric Diagnosis in Vietnam
Complete blood count (CBC) results underpin pediatric evaluation for anemia, infection, inflammation, and platelet disorders. Yet laboratories in Vietnam have largely relied on reference intervals derived... Read more
Spectral Flow Cytometry Assay Enhances MRD Detection in Multiple Myeloma
Minimal residual disease (MRD) monitoring is pivotal in multiple myeloma, where persistent malignant plasma cells drive relapse risk and help guide therapy decisions. In the United States, approximately... Read moreImmunology
view channel
Study Reveals Immune Mechanism Driving Severe COVID-19 Progression
Severe COVID-19 has highlighted gaps in understanding of early antiviral responses, particularly why some patients deteriorate despite timely care. Type I interferons are central to host defense, yet their... Read more
Antibody Profiling Identifies Preclinical Inflammatory Bowel Disease Years Before Diagnosis
Inflammatory bowel disease often develops after a prolonged symptom-free period, complicating timely recognition and clinical intervention. Limited understanding of immune activity during this silent phase... Read more
Ultrasensitive Blood Test Detects Sjögren’s Signature Years Before Diagnosis
Sjögren’s disease is a common autoimmune condition that can be difficult to recognize early, leading to delayed diagnosis and persistent symptom burden. It affects around half a million people in the UK... Read more
New Assays Expand Cytokine Testing for Transplant and Immunocompromised Patients
Eurofins Viracor has introduced three plasma-based assays—CXCL9 (Test Code 33607), CXCL10 (Test Code 33609), and interleukin-18 (IL-18) (Test Code 33611)—expanding its immunology testing menu for transplant... Read moreMicrobiology
view channel
New Sensitive Blood Assay Detects Tuberculosis Antigen Directly in Blood
Tuberculosis continues to be a leading global infectious disease, and diagnosis still hinges on sputum samples that many patients cannot produce early in illness. Delays in confirming Mycobacterium tuberculosis... Read more
High-Throughput Automated Platform to Advance Latent Tuberculosis Testing
Testing for tuberculosis remains a persistent global need, with demand driven by immigration screening, pre-treatment evaluation for immunosuppressive therapies, and public health programs.... Read morePathology
view channel
AI Pathology Tool Predicts Relapse Risk in Stage II Colorectal Cancer
Bowel cancer is Australia’s fourth most commonly diagnosed cancer and the second leading cause of cancer death, while remaining the third most common cancer worldwide. In stage-two disease, determining... Read more
AI Pathology Tool Stratifies Rectal Cancer to Guide Chemoradiotherapy
Choosing intensified regimens for locally advanced rectal cancer is challenging because these therapies can cause serious side effects. Colorectal cancer is the fourth-most fatal cancer in the UK, and... Read more
PD-L1 Assay Guides Pembrolizumab Eligibility in Ovarian, Fallopian Tube, and Peritoneal Cancers
Agilent Technologies’ PD-L1 IHC 22C3 pharmDx (Code SK006) has received European Union certification as a companion diagnostic to aid in identifying patients with epithelial ovarian, fallopian tube, or... Read moreTechnology
view channel
Training Device Improves Accuracy of Pooled Molecular Diagnostics
High-throughput molecular diagnostics have transformed infectious disease detection, but many workflows remain difficult to execute accurately without extensive training. Sample pooling can cut per‑test... Read more
New CE-Certified Software Advances Whole-Genome Cancer Testing
European hospitals are increasingly using comprehensive tumor genomics to guide therapy, but routine whole genome sequencing (WGS) requires validated, regulation-compliant workflows. A newly CE-certified... Read more
National Rare Disease Registry Standardizes Genetic and Clinical Data for Coordinated Care
Rare diseases collectively impose a significant clinical burden despite their individual rarity, often involving multisystem presentations and prolonged diagnostic journeys. Limited specialist expertise... Read moreIndustry
view channelLumiQuick Advances Oxidative Stress Research with Expanded AOXRE Portfolio
LumiQuick Diagnostics, Inc. (Santa Clara, CA, USA) has announced the addition of the AOXRE product line to its portfolio and introduced expanded services to help biotechnology and diagnostic companies... Read more
Collaboration Advances Sputum-Based Diagnostics for Asthma and COPD
Asthma and chronic obstructive pulmonary disease are highly prevalent inflammatory airway conditions, affecting more than 40 million Americans and more than 650 million people worldwide.... Read more








